Digitisation | March 18, 2023
Lupin Digital Health reveals results of digital therapeutics study with ACS patients
The one-year-long study was aimed to evaluate the efficacy of LDH's digital therapeutics platform
The one-year-long study was aimed to evaluate the efficacy of LDH's digital therapeutics platform
Chronic Kidney Disease is a growing epidemic with 850 million people affected worldwide.
Receives regulatory approval for its molecule ‘Selumetinib’ in India
First approval for Daiichi Sankyo and AstraZeneca’s ENHERTU in China
New subgroup analysis from Phase III ARASENS trial shows that darolutamide plus androgen deprivation therapy (ADT) in combination with docetaxel increased overall survival (OS)
eSanjeevani 2.0 will enhance the telemedicine experience further with a plethora of new features both in terms of technology as well as innovation
With the on-going relentless efforts to imbibe new developments in ART, India will make significant progress in ensuring the best facilities and care for fertility to couples in India
Asthma patients are more likely to have an asthma attack during winter
Valentas and Arnipin are indicated to reduce repeated hospitalization and the risk of cardiovascular death among adult patients with chronic mild to moderate heart failure
AUR101, with a good ADME/PK profile and high bioavailability, has demonstrated inhibition of IL-17A in whole blood from psoriasis patients
Subscribe To Our Newsletter & Stay Updated
